Quick Dispatch:
Your teva glp-1 Teva wins US obesity approval for its GLP-1 generic liraglutide | News orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your teva glp-1 Teva wins US obesity approval for its GLP-1 generic liraglutide | News ships.
Need Help?
Questions about teva glp-1 Teva wins US obesity approval for its GLP-1 generic liraglutide | News, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for teva glp-1 Teva wins US obesity approval for its GLP-1 generic liraglutide | News in your area.
On August 28, 2025, the US Food and Drug Administration (FDA) approved Teva Pharmaceuticals' generic to Novo Nordisk's Saxenda® (liraglutide injection). This is the first generic glucagon-like peptide-1 (GLP-1) agonist approved for
22.11
Teva Launches First-Ever Generic GLP-1: A Game-Changer for Diabetes and Weight Management
23.60
Novel GLP-1 Pill Tops Oral Semaglutide for Diabetes
21.27
Teva Launches First Generic GLP-1 Drug for Obesity
27.35
Diabetes patients now have access to first generic GLP-1 medication: ‘More accessible and affordable’
21.44
Teva introduces first U.S. generic GLP-1 drug for diabetes
22.53
FDA Approves First Generic GLP-1 Weight Loss Drug
26.65
